News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Medicare beneficiaries may face higher premiums next year for their Part D drug plans, as the federal government plans to end subsidies that helped mitigate price increases in the program. The Trump administration will not continue the subsidies beyond 2026, The Wall Street Journal reported. About 25 million Medicare recipients are enrolled in a stand-alone Part D plan for their drug coverage.
Stock Market Today: The Dow Jones index dropped Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. SK Hynix sold off.
July 29 () - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed under U. Shares of the medical device maker rose 12% in premarket trading.
July 29 (Reuters) - GE HealthCare on Wednesday beat Wall Street estimates for second-quarter profit, helped by strong demand for its diagnostic and imaging devices and refunds of tariffs imposed
Gold is currently pulling back after a blistering return in 2025.
Retail sentiment remains ‘bearish’ on SPY and QQQ. Further weakness in QQQ will put it on track for the longest losing streak since August 2025.
Nearly a third of Americans say they have shoplifted at some point in their lives, according to a new LendingTree survey — a figure that has climbed as high prices for groceries, housing and insurance continue to strain household budgets. The survey found that 30% of respondents admitted to ...
GNTX beat Q2 earnings estimates as favorable product mix, tight cost control and tariff reimbursements offset softer auto demand and lower revenues.
(Bloomberg) -- Two months after Ford Motor Co. became the latest old-economy manufacturer to be swept up in the artificial-intelligence rally, investors are looking for proof the enthusiasm was justified. Most Read from BloombergNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip Rout Deepens on Circular Funding, China Competition FearsCitadel Securities Sees Warsh Delivering Surprise Fed HikeDeepSeek Suspends Fundraising After Viral US-China PostsS&P 500 Wobbles as AI Angst Offsets Oi
(Bloomberg) -- Tesla Inc. struck a long-term deal to buy electricity from a KKR & Co.-backed solar and battery project in Arizona, developer ContourGlobal said. Most Read from BloombergNvidia’s $750 Billion in Deals Reignite Circular AI FearsChip Rout Deepens on Circular Funding, China Competition FearsDeepSeek Suspends Fundraising After Viral US-China PostsCitadel Securities Sees Warsh Delivering Surprise Fed HikeS&P 500 Wobbles as AI Angst Offsets Oil Decline: Markets WrapThe firm will sell 90
In crypto news today (July 28), Bitcoin has dropped nearly -3% overnight, losing $65,000 and looking likely to retest $60,000 ahead of today’s FOMC meeting. Liquidations have picked up as a result, with over $600M in positions blown up since yesterday, and unsurprisingly, more than $530M of that figure has ...
Caterpillar has quietly become one of Wall Street's most unexpected AI infrastructure plays, but a 10% pullback from all-time highs and mounting tariff costs raise a critical question about whether the bull case still holds.
Plus, America’s big cities are rapidly losing kids, and Trump puts off a major escalation of his military campaign against Iran.
Stocks looked set to rally on Monday as oil prices retreated, helping to ease investors’ worries about higher inflation at the start of a week that will be defined by a Federal Reserve policy decision and a slew of mega-cap tech earnings. Nasdaq 100 futures jumped 1.4%. The three major indexes all dropped last week as tensions flared in the Middle East, driving up oil prices and bolstering the case for the Fed to hike interest rates.
Iran and Oman are also in talks that center around having Iran run vessel transit through the Strait of Hormuz with fewer restrictions on ships.
The next key catalyst for this cannabis stock lies in the hands of a U.S. Federal Government agency.
Federal AI contracts are pouring into enterprise software order books, and two of the sector's most beaten-down stocks are suddenly surging. Whether today's rally marks a genuine turning point or a fleeting squeeze depends on details buried inside fresh earnings reports and a blockbuster government deal.
(Bloomberg) -- Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, surged 67% on Friday after raising $128.7 million in an upsized initial public offering.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesSpaceX Turns Away Falcon Customers in Majo
Oracle Powers Higher After Landing Potential $7 Billion Federal Contract
(Bloomberg) -- Corporate earnings strong enough to beat the highest expectations in years have failed to impress investors fretting about AI spending and economic growth.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesAlphabet Falls as $205 Billion Spending Plan Fuels AI Cost FearAbo
(Bloomberg) -- Global bonds are being pummeled by the latest resurgence in energy prices, delivering losses to investors who bet the worst of this year’s rout was over and teeing up credibility tests for central bankers.Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump Rebuilds Tariffs With New Levies on 60 EconomiesAlphabet Falls a
President Donald Trump’s threat of 100% tariffs on generic drugs would seem to be a problem for Teva Pharmaceutical. It might not be.
Shares of Cleveland-Cliffs are up about 16% after the steelmaker forecast profits in the back half of the year will be the strongest in five years. Cliffs is the largest producer of steel for the automotive industry. Goncalves said he would consider restarting an idle steel mill in Dearborn, Mich., if automakers commit to relocating more vehicle production to the U.S. from Mexico, Canada or South Korea.
(Bloomberg) -- German bond yields rose to the highest level since 2011 as surging energy prices and mounting inflation expectations fueled bets on interest-rate hikes ahead of the European Central Bank’s decision later Thursday. Most Read from BloombergRetina Chip Designed to Restore Sight to Go on Sale in EuropeHegseth Turns to UNC, Virginia Tech After Dropping Ivy LeagueApple Plans Overhaul of MacBooks, iMac in Push to Meet AI DemandTrump’s 100% Generic Drug Duty Threatens US Low-Cost SupplyAl
Wabtec was the No. 2 S&P 500 stock on Wednesday after the supplier of locomotives and railcars for freight and passenger service topped Q2 earnings estimates and raised its full-year outlook. Strong international performance, backlog growth and a wider profit margin — despite tariffs — powered Wabtec shares toward the top of a buy zone. Results: Wabtec posted adjusted earnings per share of $2.76, up 21.6% from a year ago and 16 cents ahead of estimates.
Infleqtion received three Department of Energy research projects and led gains among the companies tied to the initiative.